课题基金 / 基金详情

Inhibition of Fibrosis and Inflammation by Triple Therapy with Pirfenidone, Edaravone, and Erythropoietin in Rabbits with Drug-Induced Lung Injury : Computed Tomography-Pathological Correlation

Inhibition of Fibrosis and Inflammation by Triple Therapy with Pirfenidone, Edaravone, and Erythropoietin in Rabbits with Drug-Induced Lung Injury : Computed Tomography-Pathological Correlation
吡非尼酮、依达拉奉和促红细胞生成素三联疗法对药物性肺损伤家兔纤维化和炎症的抑制作用:计算机断层扫描-病理相关性
批准号:
22791185
负责人:
WATANABE Shobu
金额:
$2.08万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We divided drug-induced lung injury rabbits into 3groups ; the control group(G1), pirfenidone group(G2), and a three-drug combination group(G3)(pirfenidone, edaravone, and erythropoietin). CT on day 28, G3 tended to exhibit a smaller area with abnormal opacity compared with G1(p=0. 071). In microscopic specimens, the average fibrosis score showed a significant difference between G1 and G3(p<0. 05). Moreover, the average fibrosis score tended to be smaller in G3 than in G2(p<0. 1).From the above, administration of pirfenidone alone suppressed the advancement of drug-induced lung injury, but the three-drug combination prevented further progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金